1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
(
- Contribution to journal › Article
- 2014
-
Mark
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line.
(
- Contribution to journal › Article
-
Mark
Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
(
- Contribution to journal › Article
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
(
- Contribution to journal › Article
-
Mark
HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors - Considerations for Successful Immunotherapy.
(
- Contribution to journal › Article
-
Mark
Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory.
(
- Contribution to journal › Article
- 2013
-
Mark
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
(
- Contribution to journal › Article
- 2011
-
Mark
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
(
- Contribution to journal › Article
- 2010
-
Mark
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
(
- Contribution to journal › Article
- 2009
-
Mark
Immunizations With IFN gamma Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas
(
- Contribution to journal › Article